Abstract:A description of the EBR-II shield and the methods employed in arriving at the final design are presented. The major shield design problems for that reactor are enumerated and discussed.
“…Work by S.A. Kamal [3], and by Grotenhuis, McArthy, and Rossin [4] was examined for insights and key concerns.…”
Section: Historical Guidance: Design Needs For Ebr-ii and Other Lmr'smentioning
confidence: 99%
“…For FFTF and CRBR, the main concern was ensuring 10% residual ductility for permanent components (some FFTF components were designed to 5%). It is pointed out in [4] that the austenitic steels used in liquid metal cooled reactors have high initial ductilities. The integrated neutron doses required to achieve embrittlement saturation are not reached at reactor vessel locations over the lifetime of a liquid-metal-cooled system.…”
Section: Historical Guidance: Design Needs For Ebr-ii and Other Lmr'smentioning
“…Work by S.A. Kamal [3], and by Grotenhuis, McArthy, and Rossin [4] was examined for insights and key concerns.…”
Section: Historical Guidance: Design Needs For Ebr-ii and Other Lmr'smentioning
confidence: 99%
“…For FFTF and CRBR, the main concern was ensuring 10% residual ductility for permanent components (some FFTF components were designed to 5%). It is pointed out in [4] that the austenitic steels used in liquid metal cooled reactors have high initial ductilities. The integrated neutron doses required to achieve embrittlement saturation are not reached at reactor vessel locations over the lifetime of a liquid-metal-cooled system.…”
Section: Historical Guidance: Design Needs For Ebr-ii and Other Lmr'smentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.